Logo image of BV

BRIGHTVIEW HOLDINGS INC (BV) Stock Fundamental Analysis

NYSE:BV - New York Stock Exchange, Inc. - US10948C1071 - Common Stock - Currency: USD

15.8  +0.05 (+0.32%)

Fundamental Rating

3

Taking everything into account, BV scores 3 out of 10 in our fundamental rating. BV was compared to 83 industry peers in the Commercial Services & Supplies industry. While BV seems to be doing ok healthwise, there are quite some concerns on its profitability. BV is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BV was profitable.
BV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BV reported negative net income in multiple years.
Each year in the past 5 years BV had a positive operating cash flow.
BV Yearly Net Income VS EBIT VS OCF VS FCFBV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

1.2 Ratios

BV has a Return On Assets (-0.05%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -0.10%, BV is in line with its industry, outperforming 46.99% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 2.95%, BV is in line with its industry, outperforming 43.37% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BV is significantly below the industry average of 11.67%.
The last Return On Invested Capital (2.95%) for BV is above the 3 year average (2.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.05%
ROE -0.1%
ROIC 2.95%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
BV Yearly ROA, ROE, ROICBV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6

1.3 Margins

In the last couple of years the Profit Margin of BV has declined.
BV's Operating Margin of 4.50% is in line compared to the rest of the industry. BV outperforms 45.78% of its industry peers.
In the last couple of years the Operating Margin of BV has declined.
BV has a worse Gross Margin (23.23%) than 66.27% of its industry peers.
In the last couple of years the Gross Margin of BV has declined.
Industry RankSector Rank
OM 4.5%
PM (TTM) N/A
GM 23.23%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
BV Yearly Profit, Operating, Gross MarginsBV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BV is destroying value.
BV has more shares outstanding than it did 1 year ago.
BV has less shares outstanding than it did 5 years ago.
BV has a better debt/assets ratio than last year.
BV Yearly Shares OutstandingBV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BV Yearly Total Debt VS Total AssetsBV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BV has an Altman-Z score of 1.57. This is a bad value and indicates that BV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.57, BV is doing worse than 67.47% of the companies in the same industry.
BV has a debt to FCF ratio of 8.01. This is a slightly negative value and a sign of low solvency as BV would need 8.01 years to pay back of all of its debts.
BV's Debt to FCF ratio of 8.01 is fine compared to the rest of the industry. BV outperforms 63.86% of its industry peers.
BV has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.45, BV perfoms like the industry average, outperforming 56.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 8.01
Altman-Z 1.57
ROIC/WACC0.37
WACC8.06%
BV Yearly LT Debt VS Equity VS FCFBV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.42 indicates that BV should not have too much problems paying its short term obligations.
BV's Current ratio of 1.42 is on the low side compared to the rest of the industry. BV is outperformed by 60.24% of its industry peers.
A Quick Ratio of 1.42 indicates that BV should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.42, BV is in line with its industry, outperforming 55.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
BV Yearly Current Assets VS Current LiabilitesBV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

BV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.26%.
The Earnings Per Share has been decreasing by -8.19% on average over the past years.
The Revenue has decreased by -2.85% in the past year.
BV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.85% yearly.
EPS 1Y (TTM)5.26%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%27.27%
Revenue 1Y (TTM)-2.85%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-1.53%

3.2 Future

BV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.16% yearly.
Based on estimates for the next years, BV will show a small growth in Revenue. The Revenue will grow by 1.99% on average per year.
EPS Next Y17.5%
EPS Next 2Y14.16%
EPS Next 3Y16.16%
EPS Next 5YN/A
Revenue Next Year-0.91%
Revenue Next 2Y0.94%
Revenue Next 3Y1.99%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BV Yearly Revenue VS EstimatesBV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
BV Yearly EPS VS EstimatesBV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.75 indicates a rather expensive valuation of BV.
Based on the Price/Earnings ratio, BV is valued a bit cheaper than the industry average as 67.47% of the companies are valued more expensively.
BV is valuated rather cheaply when we compare the Price/Earnings ratio to 27.51, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 16.16, the valuation of BV can be described as correct.
Based on the Price/Forward Earnings ratio, BV is valued a bit cheaper than the industry average as 71.08% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 35.58. BV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 19.75
Fwd PE 16.16
BV Price Earnings VS Forward Price EarningsBV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

BV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BV is cheaper than 78.31% of the companies in the same industry.
75.90% of the companies in the same industry are more expensive than BV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.09
EV/EBITDA 7.88
BV Per share dataBV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BV's earnings are expected to grow with 16.16% in the coming years.
PEG (NY)1.13
PEG (5Y)N/A
EPS Next 2Y14.16%
EPS Next 3Y16.16%

0

5. Dividend

5.1 Amount

BV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BRIGHTVIEW HOLDINGS INC

NYSE:BV (7/15/2025, 11:04:35 AM)

15.8

+0.05 (+0.32%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners67.56%
Inst Owner Change0%
Ins Owners3.05%
Ins Owner Change0.44%
Market Cap1.51B
Analysts81.11
Price Target20.46 (29.49%)
Short Float %8.28%
Short Ratio6.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP-1988.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.9%
Min EPS beat(2)1.9%
Max EPS beat(2)21.9%
EPS beat(4)2
Avg EPS beat(4)4.4%
Min EPS beat(4)-4.54%
Max EPS beat(4)21.9%
EPS beat(8)4
Avg EPS beat(8)-2%
EPS beat(12)6
Avg EPS beat(12)7.72%
EPS beat(16)7
Avg EPS beat(16)3.83%
Revenue beat(2)0
Avg Revenue beat(2)-2.62%
Min Revenue beat(2)-4.84%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-2.51%
Min Revenue beat(4)-4.84%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-3.49%
Revenue beat(12)1
Avg Revenue beat(12)-2.5%
Revenue beat(16)3
Avg Revenue beat(16)-1.65%
PT rev (1m)1.9%
PT rev (3m)4.15%
EPS NQ rev (1m)1.61%
EPS NQ rev (3m)-1.92%
EPS NY rev (1m)1.58%
EPS NY rev (3m)2.7%
Revenue NQ rev (1m)-2.89%
Revenue NQ rev (3m)-3.54%
Revenue NY rev (1m)-1.67%
Revenue NY rev (3m)-1.36%
Valuation
Industry RankSector Rank
PE 19.75
Fwd PE 16.16
P/S 0.55
P/FCF 15.09
P/OCF 6.08
P/B 0.85
P/tB N/A
EV/EBITDA 7.88
EPS(TTM)0.8
EY5.06%
EPS(NY)0.98
Fwd EY6.19%
FCF(TTM)1.05
FCFY6.63%
OCF(TTM)2.6
OCFY16.46%
SpS28.64
BVpS18.56
TBVpS-3.44
PEG (NY)1.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.05%
ROE -0.1%
ROCE 4.36%
ROIC 2.95%
ROICexc 3.11%
ROICexgc 14.3%
OM 4.5%
PM (TTM) N/A
GM 23.23%
FCFM 3.66%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
ROICexc(3y)2.47%
ROICexc(5y)2.14%
ROICexgc(3y)10.98%
ROICexgc(5y)10.41%
ROCE(3y)3.54%
ROCE(5y)3.05%
ROICexcg growth 3Y-0.5%
ROICexcg growth 5Y-6.24%
ROICexc growth 3Y6.57%
ROICexc growth 5Y-3.78%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 8.01
Debt/EBITDA 2.91
Cap/Depr 97.88%
Cap/Sales 5.42%
Interest Coverage 1.98
Cash Conversion 90.41%
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 1.57
F-Score4
WACC8.06%
ROIC/WACC0.37
Cap/Depr(3y)57.78%
Cap/Depr(5y)51.34%
Cap/Sales(3y)3.08%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.26%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%27.27%
EPS Next Y17.5%
EPS Next 2Y14.16%
EPS Next 3Y16.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.85%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-1.53%
Revenue Next Year-0.91%
Revenue Next 2Y0.94%
Revenue Next 3Y1.99%
Revenue Next 5YN/A
EBIT growth 1Y4.42%
EBIT growth 3Y7.78%
EBIT growth 5Y-2.67%
EBIT Next Year78.32%
EBIT Next 3Y26.64%
EBIT Next 5YN/A
FCF growth 1Y195.27%
FCF growth 3Y13.41%
FCF growth 5Y9.77%
OCF growth 1Y107.19%
OCF growth 3Y11.48%
OCF growth 5Y3.91%